POLICY BRIEF

Seizing Opportunities to Achieve
the WHO Global Diabetes Goals

The World Health Organization (WHO) has set an ambitious global target to reduce the health and economic burden of diabetes, with a particular focus on equitable access to prevention, diagnosis, treatment, and care. With over 830 million adults living with diabetes globally in 2022, a number expected to rise to 643 million by 2030, innovative approaches are essential to curb this trajectory. Additionally, efforts to mitigate the detrimental health impact of uncontrolled type-1 and type-2 diabetes contribute to achieving Sustainable Development Goal 3.4, notably reducing premature mortality from non-communicable diseases (NCDs) by one-third by 2030. This Fast-Track Health policy brief highlights opportunities to achieve the WHO’s diabetes goals, illustrated through five case studies, and provides recommendations for municipal, national, and regional health authorities.

Digital Glucose Monitoring and Insulin Delivery in India: India faces a high burden of diabetes, with over 74 million cases reported in 2021, 95% of which is type-2 diabetes). To improve glycemic control, a program was launched that integrated continuous glucose monitoring (CGM) devices and AI-enabled insulin delivery systems. These tools provided real-time glucose data and automated insulin dose adjustments, enhancing patient adherence and outcomes. Patients experienced a 25% improvement in average HbA1c levels within six months. However, challenges included the affordability of these devices and the need for user-friendly training programs. Public-private partnerships facilitated subsidized costs, expanding accessibility for low-income populations (Narayan et al., 2022).

Remote Diabetes Management in the United States: Kaiser Permanente Georgia implemented a comprehensive telehealth program to maintain a continuity of diabetes care while minimizing in-person visits to reduce COVID-19 exposure risks. The program utilized remote patient monitoring (RPM) tools, including CGM devices and telemedicine consultations, to track patients’ glycemic control and adjust treatment plans as needed. Healthcare providers conducted virtual visits, during which they reviewed CGM data, discussed lifestyle modifications, and made necessary medication adjustments. Patients received education on using digital tools and interpreting their glucose data. A study evaluating this program found that the proportion of patients achieving target HbA1c levels remained stable during the pandemic, indicating that remote management effectively sustained glycemic control (Oveido et al., 2024).

Community-Led Diabetes Prevention in Mexico: In Mexico, where type-2 diabetes is a leading cause of mortality, a community-led program focused on lifestyle interventions for high-risk populations. Trained community health workers (CHWs) used a smartphone app to track participants’ physical activity, dietary habits, and blood sugar levels. Over two years, participants reduced their risk of developing type-2 diabetes by 20% compared to a control group. This program underscored the importance of culturally tailored interventions, with CHWs serving as trusted advocates in communities. The program also demonstrated the scalability of mobile health (mHealth) solutions when combined with local expertise (Hernández et al., 2023).

Type-1 Diabetes Management in Sweden: Sweden has been a leader in advancing care for individuals with type-1 diabetes through the integration of CGM devices and insulin pump technology into routine clinical care. A national policy provided government subsidies for CGM devices, ensuring that all patients with type-1 diabetes, regardless of socioeconomic status, could access this life-changing technology. The policy was accompanied by a structured rollout in healthcare settings. Patients received education on using CGM devices and understanding data to make informed decisions about diet, exercise, and insulin dosing. The initiative was further supported by telemedicine services. A study published in 2022 reported a 25% reduction in severe hypoglycemia episodes and a 30% improvement in HbA1c levels among patients using CGM devices (Eliasson et al., 2024).

Workplace Wellness Programs in the United States: A U.S.-based corporate wellness program targeted employees at risk for type-2 diabetes through digital health coaching and biometric screening. AI algorithms identified high-risk individuals and offered personalized lifestyle modification plans. Participants experienced a 10% reduction in weight and a 12% improvement in insulin sensitivity over a year. The initiative demonstrated the value of leveraging workplace environments to reach adults who might not otherwise engage with healthcare systems. Lessons learned included the importance of employee buy-in and ongoing incentives to sustain employer participation (Johnson et al., 2021).

Efforts to prevent and manage diabetes face a multitude of challenges that hinder progress, particularly in low-resource settings. Access to advanced technologies like CGM devices and insulin pumps remains inequitable, with affordability posing a significant barrier even in high-income countries. Health systems often lack the infrastructure and trained personnel needed to implement and support comprehensive diabetes care, especially in rural or underserved areas. Sustained lifestyle modifications, a cornerstone of type-2 diabetes prevention, are difficult to maintain without ongoing community and healthcare support. Additionally, the growing burden of diabetes globally places immense strain on healthcare systems, requiring integration of care with other chronic disease management to avoid fragmentation. These challenges are compounded by disparities in access to educational resources, which limit patient understanding of effective self-management strategies.

Despite these challenges, there are substantial opportunities to improve diabetes outcomes through innovative approaches and strategic investments. Digital health technologies, such as mobile apps and telemedicine platforms, provide scalable solutions for self-monitoring, adherence support, and remote consultations, particularly in geographically dispersed areas. Community-based interventions have the power of leveraging local resources and peer support to promote sustainable lifestyle changes. Integration of advanced technologies, as seen in programs focused on the adoption of CGM and sensor-augmented pumps, can significantly improve glycemic control and quality of life for patients with type-1 diabetes. Furthermore, cross-sector collaboration between governments, healthcare providers, and private companies enables resource mobilization and technological innovation, making preventive and therapeutic tools more accessible. These opportunities highlight the potential for tailored, equity-focused strategies to reduce the global burden of diabetes aligned with WHO goals.